Ardent Health Partners, LLC (NYSE:ARDT) Stock Position Raised by Sei Investments Co.

Sei Investments Co. lifted its stake in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) by 27.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 176,866 shares of the company's stock after purchasing an additional 38,347 shares during the quarter. Sei Investments Co. owned about 0.12% of Ardent Health Partners worth $3,021,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Charles Schwab Investment Management Inc. acquired a new stake in Ardent Health Partners in the third quarter worth $526,000. BNP Paribas Financial Markets bought a new position in shares of Ardent Health Partners during the third quarter worth about $42,000. MetLife Investment Management LLC acquired a new stake in shares of Ardent Health Partners in the 3rd quarter worth about $135,000. Centiva Capital LP bought a new stake in Ardent Health Partners in the 3rd quarter valued at about $469,000. Finally, Point72 Asset Management L.P. acquired a new position in Ardent Health Partners during the 3rd quarter valued at about $27,428,000.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on ARDT shares. Truist Financial dropped their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Morgan Stanley lowered their target price on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 21st. Stephens reiterated an "overweight" rating and set a $22.00 price target on shares of Ardent Health Partners in a research report on Tuesday, April 1st. Royal Bank of Canada decreased their price target on Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Tuesday, March 4th. Finally, JPMorgan Chase & Co. restated a "neutral" rating and set a $20.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $21.18.

Remove Ads

Ardent Health Partners Price Performance

NYSE:ARDT traded down $0.16 during mid-day trading on Tuesday, reaching $11.90. 295,815 shares of the stock were exchanged, compared to its average volume of 407,682. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The business has a fifty day moving average price of $14.08 and a 200 day moving average price of $15.94. Ardent Health Partners, LLC has a 1-year low of $11.60 and a 1-year high of $20.72.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.31. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.48 billion. As a group, equities analysts expect that Ardent Health Partners, LLC will post 1.23 EPS for the current year.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.